Document Detail

Early toxicity of recombinant interleukin-2 in cats.
MedLine Citation:
PMID:  1772328     Owner:  NLM     Status:  MEDLINE    
Studies were conducted in cats to determine whether this species could serve as an animal model for the therapeutic toxicity of recombinant interleukin-2 in humans, and to establish the role of the area postrema in the causation of recombinant interleukin-2-induced vomiting. Injections of recombinant interleukin-2 (3.6 x 10(6) IU/kg, i.m.), given once every 24 hr for one to three days, evoked repeated vomiting in 4 out of 6 area postrema intact cats and in 3 out of 3 area postrema-ablated cats. These results suggest that the area postrema is not essential for the emetic action of recombinant interleukin-2. In anesthetized intact cats, no remarkable changes in ventilation, blood pressure, heart rate or blood pH were observed over 4.5 to 54 hr of continuous physiological recording after i.v. injections of recombinant interleukin-2 to a total dose as high as 27 x 10(6) IU/kg. Cat lymphocytes responded appropriately to the cytokinetic action of human recombinant interleukin-2.
S F Gonsalves; B E Landgraf; T L Ciardelli; H L Borison
Related Documents :
12100068 - Chromogranin 'a' in normal subjects, essential hypertensives and adrenalectomized patie...
7889108 - Recent advances in endothelin research on cardiovascular and endocrine systems.
6831738 - Marital interaction and adjustment in patients with essential hypertension.
602178 - "timolol in essential hypertension" a preliminary report.
687468 - Arterial hypertension in immediate postoperative period after valve replacement.
1763688 - Factors associated with postoperative hypertension complicating carotid endarterectomy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Archives internationales de pharmacodynamie et de thérapie     Volume:  310     ISSN:  0003-9780     ISO Abbreviation:  Arch Int Pharmacodyn Ther     Publication Date:    1991 Mar-Apr
Date Detail:
Created Date:  1992-02-21     Completed Date:  1992-02-21     Revised Date:  2012-01-12    
Medline Journal Info:
Nlm Unique ID:  0405353     Medline TA:  Arch Int Pharmacodyn Ther     Country:  BELGIUM    
Other Details:
Languages:  eng     Pagination:  175-85     Citation Subset:  IM    
Department of Surgery, Dartmouth Medical School, Hanover, NH 03756.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Pressure / drug effects
Carbon Dioxide / blood
Cell Division / drug effects
Cerebral Ventricles / physiology
Emetics / pharmacology
Heart Rate / drug effects
Hemodynamics / drug effects
Interleukin-2 / toxicity*
Recombinant Proteins / toxicity
Respiration / drug effects
T-Lymphocytes / drug effects
Time Factors
Grant Support
Reg. No./Substance:
0/Emetics; 0/Interleukin-2; 0/Recombinant Proteins; 124-38-9/Carbon Dioxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Compound M & B 39890A [N-(3-imidazol-1-ylpropyl)- 2-(3-trifluoromethylbenezensulphonamido)-benzamide...
Next Document:  Relaxation of coronary artery smooth muscle cells.